[Safety assessment of nanomaterials using toxicokinetics and toxicoproteome analysis].
暂无分享,去创建一个
Yasuo Tsutsumi | Tomoaki Yoshikawa | Hiromi Nabeshi | Takayoshi Imazawa | Shin-Ichi Tsunoda | Y. Tsutsumi | T. Imazawa | T. Yoshikawa | S. Tsunoda | H. Nabeshi
[1] A. D. McDonald,et al. The epidemiology of mesothelioma in historical context. , 1996, The European respiratory journal.
[2] P E Enterline,et al. Type of asbestos and respiratory cancer in the asbestos industry. , 1973, Archives of environmental health.
[3] R. Lilis,et al. ASBESTOS DISEASE IN UNITED STATES SHIPYARDS * , 1979, Annals of the New York Academy of Sciences.
[4] C. Wen,et al. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data , 2003, Occupational and environmental medicine.
[5] Wei Li,et al. Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases. , 2008, Toxicology letters.
[6] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.
[7] S. Philippou,et al. Health hazards due to the inhalation of amorphous silica , 2001, Archives of Toxicology.
[8] J. Kanno,et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. , 2008, The Journal of toxicological sciences.
[9] Craig A. Poland,et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.
[10] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.